Relevant bibliographies by topics / Diabetes mellitus Patients

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Diabetes mellitus Patients'

Author: Grafiati
Published: 27 June 2021
Last updated: 15 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Diabetes mellitus Patients.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Diabetes mellitus Patients"

1

Pareek, Jitendra, and Kashyap Buch. "Prevalence of Diabetic Retinopathy in Diabetes Mellitus Patients in Bhuj, Kutch." Indian Journal of Emergency Medicine 4, no. 3 (2018): 137–40. http://dx.doi.org/10.21088/ijem.2395.311x.4318.4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Jackuliak, Peter, Magdaléna Kovářová, Martin Kužma, and Juraj Payer. "Osteoporosis in diabetes mellitus patients." Vnitřní lékařství 67, no. 5 (August 25, 2021): 291–95. http://dx.doi.org/10.36290/vnl.2021.076.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

K, Madhavan. "Study on Mean Platelet Volume in Type 2 Diabetes Mellitus Patients vs Non Diabetic Patients." Journal of Medical Science And clinical Research 05, no. 03 (March 8, 2017): 18573–77. http://dx.doi.org/10.18535/jmscr/v5i3.51.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Hussain, Mehmood, Syed Ahsan Ali, Syed Imran Hassan, Nazia Yazdanie, Mohammad Yawar Khan, and Moin Khan. "DIABETES MELLITUS PATIENTS." Professional Medical Journal 22, no. 11 (November 10, 2015): 1409–14. http://dx.doi.org/10.29309/tpmj/2015.22.11.873.

Full text
Abstract:
Objectives: To observe Quality of Life (QoL) in diabetes mellitus patientsafter fabrication of immediate dentures. Setting: Department of Prosthodontics in HamdardUniversity Dental Hospital, Karachi. Period: Two years from October 2011 to September 2013.Methodology: Thirty patients with established diagnoses of diabetes mellitus reported. In thisstudy by purposive non-probability sampling technique. In this study patients were selected,male and female patients were 24 and 6 respectively with the age range of 22- 74 years. Aftergetting consent Questions mention in OHIP-14 were asked from the patients on 1st visit and2 months later after fabrication of immediate denture to assess the QoL of in these patients.Data was obtained after using SPSS-version 19. For analysis Wilcoxon Signed Ranks Testwas applied to get results. Probability level of P< 0.05 was considered statistically significant.Results: There was marked improvement in different domains of QoL in diabetes mellituspatients after fabrication of immediate dentures, most of the patients were pleased with theirprosthesis. Three patients had complained of pain on buccal side which was corrected bytrimming the overextended flange of their denture. All patients had improvement in phonetics(P value 0.01), better choice of food (P value 0.00), eating ability (P value 0.01), decreaseembarrassment (P value 0.08) and self-assurance (P value 0.025). However, effect of immediatedenture on variable like tension was not advantageous having P-value of 0.157. Conclusion: Byfabrication of immediate dentures to diabetes mellitus patients, QoL can be markedly improvedin such patients.
APA, Harvard, Vancouver, ISO, and other styles
5

Šmahelová, Alena. "Diabetes mellitus in complex older patients." Vnitřní lékařství 64, no. 11 (November 1, 2018): 1005–8. http://dx.doi.org/10.36290/vnl.2018.145.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Sheth, Neeti R., Nabilah A. Sareshwala, Sushil G. Chaudhary, and Hiren D. Matai. "Awareness about diabetes mellitus and diabetic retinopathy in patients with diabetes mellitus." International Journal of Research in Medical Sciences 5, no. 8 (July 26, 2017): 3570. http://dx.doi.org/10.18203/2320-6012.ijrms20173564.

Full text
Abstract:
Background: Awareness about diabetes mellitus and diabetic retinopathy in patients with diabetes mellitus.Methods: 50 patients of diabetes mellitus attending Pandit Deendayal Upadhyay Medical College, Rajkot, Gujarat, India, were randomly selected during January 2017 to March 2017. 11-point questionnaire obtained on detailed search of literature on published reports were administered by interviewers well versed in English and Gujarati.Results: Total of 50 patients were randomly selected.42%- females and 58% - males. Mean age - 58.5 years. Age range 40 to 71 years. Patients with good sugar control -26% and poor control - 74%. 94% of the patients were taking treatment for DM and 6% were not on any treatment. 48 % of the patients were illiterate, 10% were graduate and 42% had education below 12th standard. 50% were aware about DM affecting the eye .38% had taken eye treatment and 62% had not. 26% were aware of DM affecting eye inspite of good control and 26 % aware of the need of check-up in poor control. 40% aware of the complications related to DM.Conclusions: Better literacy rates is contributory to public awareness, however trend for poor practice needs to be radically changed with aggressive public motivation emphasizing the necessity of screening and follow ups.
APA, Harvard, Vancouver, ISO, and other styles
7

Singh, Luxmi, Lubna Ahmed, Swati Yadav, Pragati Garg, and B. B. Lal. "DIABETIC MACULAR EDEMA IN ASSOCIATION WITH DIABETIC RETINOPATHY IN PATIENTS OF TYPE 2 DIABETES MELLITUS." ERA'S JOURNAL OF MEDICAL RESEARCH 5, no. 1 (June 2018): 06–08. http://dx.doi.org/10.24041/ejmr2018.55.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Zhuravka, N. V., I. V. Shop, and Е. Т. Folusho. "The Development of Atherosclerosis in Patients with Diabetes Mellitus." Ukraïnsʹkij žurnal medicini, bìologìï ta sportu 5, no. 4 (July 21, 2020): 145–49. http://dx.doi.org/10.26693/jmbs05.04.145.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Krupelnytska, Liudmyla, and Iryna Burovska. "Motivational and Semantic Profiles in Patients with Diabetes Mellitus." Collection of Research Papers "Problems of Modern Psychology", no. 52 (May 31, 2021): 106–35. http://dx.doi.org/10.32626/2227-6246.2021-52.106-135.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

AZIZ, MUHAMMAD SHAHID. "DIABETES MELLITUS;." Professional Medical Journal 19, no. 01 (January 3, 2012): 068–72. http://dx.doi.org/10.29309/tpmj/2012.19.01.1955.

Full text
Abstract:
Objective: To determine the prevalence of Diabetes mellitus in patients of hepatitis C virus infection. Design: Prospective andobservational study. Setting: Medical Wards at Combined Military Hospital Jhelum. Period: 1st November 2009 to 31st October 2010. Method:100 cases of HCV positive on Elisa method were inducted. All cases were segregated into different states of liver disorders and were screenedfor Blood Sugar level, for one year. So as to observe the frequency of Diabetes Mellitus among HCV positive patients. Diabetes mellitus wasconsidered to be present if patients were already on diabetes treatment or fasting or random blood sugar indicated diabetes mellitus accordingto standard criteria. Results: One hundred patients were studied. Fifty five (55 %) were males and forty five (45 %) were females. The agesranged from 15 to 71 years (Mean 44.24). Out of these 100 patients, total of 28 (28%) had diabetes mellitus. Out of 100 patients, 82 patients hadchronic hepatitis C virus infection without cirrhosis and 22 (26.4 %) of these had diabetes. Twenty two patients with chronic hepatitis C, who haddiabetes mellitus, twenty (90.9 %) were non-insulin dependent diabetics and two (9.1 %) were insulin dependent. Total of 18 patients hadcirrhosis and out of these 6 patients (33.33 %) had diabetes mellitus. Six patients with cirrhosis all had non-insulin dependent diabetes mellitus.Conclusions: Patient with chronic hepatitis C virus infection and cirrhosis secondary to hepatitis C virus infection have strong association withdiabetes mellitus and great majority of them are non-insulin dependent diabetics.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Diabetes mellitus Patients"

1

Clifford, Rhonda Marise. "Pharmaceutical care in diabetes mellitus." Curtin University of Technology, School of Pharmacy, 2004. http://espace.library.curtin.edu.au:80/R/?func=dbin-jump-full&object_id=14951.

Full text
Abstract:
People with diabetes mellitus are more likely to die from cardiovascular causes than those without diabetes, and modifiable risk factors, such as hyperglycaemia, dyslipidaemia and hypertension can be targeted in intervention programs to decrease this risk. In addition to tertiary care for patients with diabetes, there is a need for simple programs to be implemented in the community that allow the benefits of improved metabolic and blood pressure control to be realised more widely. Pharmaceutical care comprises the detection, prevention and solution of drug-related problems in a quantifiable form, so that outcomes of care can be easily reviewed and monitored. Previous studies of pharmaceutical care programs in patients with diabetes do not provide conclusive evidence of the benefit of pharmaceutical care. The aim of this research was to evaluate the impact of the provision of pharmaceutical care to patients with diabetes mellitus in an Australian context. In order to develop a pharmaceutical care program, the characteristics of an Australian cohort of patients with diabetes were reviewed. The Fremantle Diabetes Study (FDS), was a community-based prospective observational study of diabetes care, control and complications in a postcode-defined region of 120 097 people surrounding the port city of Fremantle in Western Australia. It was intended that the FDS annual reviews would provide important local information in order to design and implement a prospective pharmaceutical care program. A pilot pharmaceutical care program was subsequently developed for use in a diabetes outpatient clinic. This program was then modified for use in a community-based sample of type 2 diabetes mellitus patients, drawn from the FDS cohort.
Demographic parameters, including ethnicity and treatment details, were reviewed at study entry for the full FDS cohort and then over time for a subset of patients that returned for four subsequent annual assessments. Insulin use was more common in patients of Southern European origin compared with the Anglo-Celt group irrespective of the level of glycaemia, at baseline. This difference persisted during subsequent follow-up but was not associated with improved glycaemic control. These findings demonstrated that there are important ethnic differences in the management of patients with type 2 diabetes mellitus. The pilot pharmaceutical care program was carried out in high-risk diabetes mellitus patients attending a hospital outpatient clinic. The patients had poor glycaemic control, dyslipidaemia, hypertension and/or were on three or more prescription medications. In the pharmaceutical care arm, a clinical pharmacist reviewed and monitored all aspects of the patients' drug therapy in collaboration with other health care professionals at six weekly intervals for six months. The control patients received usual outpatient care. Seventy-three patients were recruited into the study, of whom 48 (66%) were randomised to receive pharmaceutical care. One in six patients was taking complementary medicines. The pharmaceutical care program provided patients with important medication information that resulted in changes to drug therapy. However, the six-month program did not lead to an improvement in glycaemic control. The next phase of the study adapted the pilot hospital-based pharmaceutical care program to a community-based setting.
Two hundred and two type 2 diabetes mellitus FDS patients were recruited, of whom 101 (50%) were randomised to the pharmaceutical care program, and all were followed for 12-months. There were significant reductions in risk factors associated with coronary heart disease in the case but not the control group over time, specifically glycaemic control, lipid levels, and blood pressure. Glycosylated haemoglobin fell from 7.5% to 7.0% (P<0.0001), total cholesterol fell from 5 mmol/L to 4.6 mmol/L (P<0.0001), systolic blood pressure fell from 158 mmHg to 143 mmHg (P<0.0001) and diastolic blood pressure fell from 77mmHg to 71mmHg (P<0.0001). Multiple linear regression analysis confirmed that pharmaceutical care program involvement was an independent predictor of benefit after adjustment for key variables. The 10-year coronary heart disease risk for patients without a previous coronary event was reduced by 4.6% over the 12-month study period in the pharmaceutical care group (P<0.0001), while there was no change in the controls (P=0.23). This phase of the study showed that medium-term individualised pharmaceutical care reduced vascular risk factors in a community-based cohort of patients with diabetes and that provision of a multifactorial intervention can improve health outcomes in type 2 diabetes mellitus. As part of the pharmaceutical care program, a high level of complementary medicine use was found. As a result, a study of complementary medicine use was undertaken in 351 patients from the FDS. A convenience sample of FDS patients was interviewed regarding their use of complementary medicines. A literature search was conducted to assess the potential impact of these medicines on diabetes, concomitant medications or diabetes-related co-morbidities.
Eighty-three of 351 (23.6%) patients with diabetes had consumed at least one complementary medicine in the previous year and 42% (77/183) of the products potentially necessitated additional patient monitoring or could be considered potentially inappropriate for a diabetic patient. The data indicated the need for patient disclosure of complementary medicine use and adequate monitoring for complementary medicine-related adverse events, as part of the pharmaceutical care process. The pharmaceutical care model was established to provide a framework by which drug use could be improved to enhance patients' clinical and health-related quality of life outcomes. For the present study, a straightforward pharmaceutical care program was adapted from a hospital setting to a community setting, where the principal requirement was a clinical pharmacist who had completed a self-directed diabetes-training program. In this context, clinically relevant parameters improved over the course of the study period. Pharmaceutical care programs such as this can begin the process of translating the findings of large and expensive clinical trials into standard clinical practice.
APA, Harvard, Vancouver, ISO, and other styles
2

Elrayah-Eliadarous, Hind. "Economic burden of diabetes on patients and their families in Sudan /." Stockholm, 2007. http://diss.kib.ki.se/2007/978-91-7357-450-1/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Aly, Fatima Zahra. "Oral yeast infection among patients with diabetes mellitus." Thesis, University of Edinburgh, 1993. http://hdl.handle.net/1842/19616.

Full text
Abstract:
Patients with insulin-dependent diabetes mellitus (IDDM) (n = 231) or non-insulin dependent diabetes mellitus (NIDDM) (n &61 205) were selected as models for investigation of oral yeast infection in immunocompromised host. The general objectives were: 1. to assess the contributions of genetic and environmental factors to colonization by yeast and development of denture stomatitis; 2. to assess the effects of the differential distribution of H and Lewis blood group antigens on epithelial cells of secretors and non-secretors on attachment of C. albicans. Predisposing factors contributing to colonization and development of denture stomatitis are distinct for individuals with IDDM compared with those with NIDDM. By multivariate analyses, palatal and overall oral carriage of yeast among individuals with IDDM was associated with age (p < 0.01). The factor contributing to palatal carriage of yeasts among individuals with NIDDM was poor glycaemic control (p &60 0.05); carriage in the oral cavity as a whole was influenced additionally by non-secretion of ABH blood group antigens. Introduction of a denture altered the risk factors. For individuals with IDDM, overall oral carriage was associated with the presence of retinopathy (p < 0.05) and palatal carriage by poor glycaemic control (p < 0.05) and age (p < 0.05). For those with NIDDM palatal carriage was associated with continuous presence of the denture (p < 0.01) and overall oral carriage with raised plasma glucose levels (p < 0.05). Denture stomatitis was associated with poor glycaemic control among subjects with IDDM and for those with NIDDM with continuous wearing of dentures, large numbers of yeasts and non-secretion. Host pathogen interactions underlying the increased susceptibility of non-secretors to colonization were explored. Buccal epithelial cells (BEC) from secretor and non-secretor donors were assessed by flow cytometry for their ability to bind yeasts. C. albicans 2346 which expresses an adhesion that binds fucose, the immunodominant sugar of the H and Lewis blood group antigens, was used. There was a trend for BEC from non-secretors to bind more C. albicans 2346 compared with BEC from secretors. These results suggested that Lea antigen present at higher levels on cells from non-secretors might be one of the receptors for C. albicans 2346.
APA, Harvard, Vancouver, ISO, and other styles
4

Mbaya, John Kabamba. "Lay beliefs of type 2 diabetic patients at Prince Mshiyeni Memorial Hospital, Durban." Thesis, University of Limpopo (Medunsa Campus), 2010. http://hdl.handle.net/10386/547.

Full text
Abstract:
Thesis (M Med(Family Medicine))--University of Limpopo (Medunsa Campus) 2010.
Aim & Objectives Aim: To explore the lay beliefs of type 2 diabetic patients seen at Prince Mshiyeni Memorial Hospital. Objectives: To understand lay beliefs of effective life long management of type 2 diabetes patients and consequently to make recommendations of improving management of diabetes in conjunction with the findings of the study. Methodology Study Design: An exploratory study from a qualitative perspective using free attitude interviews as a data collection technique. Setting: Prince Mshiyeni Memorial Hospital a district hospital located in Umlazi in the outskirts of Durban, South Africa. Study Population: All type 2 diabetic patients above the age of 40 on treatment for 18 months or more. Ten respondents were purposively selected using maximum variation sampling strategy. Participants were asked individually to give an account of their beliefs and experience in the management of diabetes. All interviews were tape recorded, transcribed verbatim, and analyzed to identify emerging themes. Results The interpretative thematic analysis generated the following main themes: 1) Combination therapy 2) Modern versus Traditional 3) The bitter stuff 4) Traditional healers and alternative remedies viii 5) Stress: Physical, financial, emotional, psychosocial strain 6) Spiritual believes: Religious and Traditional 7) Eating right food and loose weight Conclusions This study has described most lay beliefs about the management of type 2 diabetes in this setting. The research has identified that type 2 diabetic patients seen at Prince Mshiyeni Memorial Hospital in Umlazi South of Durban held different diabetes management beliefs based on their respective initial symptom perception and beliefs, their illness origin and healing beliefs, their spiritual and traditional beliefs and values and to a significant extent, the beliefs of spouses or life partner in couples and of family members. These findings have challenged the functionality of the health care in its capacity to respond to the population expectations based on their ethnic, spiritual and cultural background.
APA, Harvard, Vancouver, ISO, and other styles
5

Zaczek, Anna. "Cataract surgery in patients with diabetes mellitus : clinical studies /." Stockholm, 1999. http://diss.kib.ki.se/1999/91-628-3557-2/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Dhatariya, Ketan. "The management of hospital in-patients with diabetes mellitus." Thesis, University of East Anglia, 2017. https://ueaeprints.uea.ac.uk/65366/.

Full text
Abstract:
In the UK, the prevalence of diabetes in adults in the general population is currently reported as just over 6% in 2014-15 [1]. This rose from a prevalence of 5.5% in 2010. However, the most recent data from the 2016 United Kingdom National Diabetes In-patient Audit reported that the prevalence of diabetes amongst hospitalised in-patients was 17% [2]. This represented a rise of over 15% since the first National Diabetes In-patient Audit was carried out in 2010, and was the same rise in prevalence seen in the general population during that time. Thus diabetes is disproportionately over represented in the in-patient population. It has been recognised for many years that in-patients with diabetes experience ‘glucose-related’ harms. Any form of dysglycaemia is associated with increased harms – in terms of poor outcomes (however that is defined) and also increased mortality [3]. For many years it was well recognised that having long term high glucose concentrations was associated with an increased risk of developing the long term micro and macrovascular complications of diabetes. It was only with the publication of the two seminal trials, the Diabetes Control and Complications Trial in type 1 diabetes and the United Kingdom Prospective Diabetes Study in type 2 diabetes that showed conclusively that in an outpatient population tight glycaemic control was associated with a reduced risk of developing those complications [4,5]. However, to date whilst there are a great deal of data to show that high glucose concentrations are associated with harm in hospitalised in-patients with diabetes, there are almost no data to show that improving glucose concentrations is associated with benefit. However, most authorities agree that glucose concentrations between 6.0 and 10.0mmol/l (with an acceptable range of 4.0 to 12.0mmol/l) are likely to be most beneficial (or rather, least likely to be associated with harm). In the UK there is an organisation called the Joint British Diabetes Societies for Inpatient Care group (JBDS), of which I am a senior member. JBDS is a group of professionals interested in the care of in-patients with diabetes. This group, which is funded by Diabetes UK and the Association of British Clinical Diabetologists and is a collaboration between these two national organisations and the National Diabetes Inpatient Specialist Nurse Group, had as it’s ‘mission statement’ the focus on producing evidence based or, where this was not possible, consensus based, clinical guidelines for the management of diabetes in hospitalised in-patients. These guidelines were designed to be used by non-specialists, and written in a user friendly way to make them clinically useful. I have been involved in writing or contributing to most of the guidelines produced by the group, and have been the lead author on two of the most widely read / used documents – peri-operative care and diabetic ketoacidosis. Indeed, as a result of my involvement in these writing groups, I am now recognised as an international expert on these two subjects. I am regularly invited to speak on these subjects, but also invited to write about them as well. This thesis is a journey through various aspects of my involvement in in-patient care for patients with diabetes from the time I was first appointed as a consultant in Norwich in 2004 to the spring of 2017. In particular my hypothesis is that because of the work I and others have published, the management of in-patients with diabetes has improved the care of this vulnerable group.
APA, Harvard, Vancouver, ISO, and other styles
7

Manfredi, M. "Characteristics of Candida isolates from patients with diabetes mellitus." Thesis, University College London (University of London), 2006. http://discovery.ucl.ac.uk/1444965/.

Full text
Abstract:
The present research has investigated the molecular characterization of oral yeasts in healthy individuals from different dental clinical settings in the United Kingdom, and patients from the UK and Italy who were affected by diabetes mellitus (DM) to determine the impact of DM upon candidal infection of the mouth. In the present study of patients with DM from the UK and Italy a lower than expected incidence of oral candidal infections (7/249, 2.8%) was observed. The presence of oral yeasts and genotypic diversity of C. albicans was also not influenced by DM. There was no significant difference between the presence of oral yeasts in Italian and UK DM patients. However, more (p=0.04) C. dubliniensis isolates were found in non-DM individuals. Higher levels of Candida adhesion to fibronectin-coated paramagnetic beads were observed in isolates from DM patients. Isolates from patients with low oral yeast loads adhered significantly (p=0.0T) more than those from patients with high oral yeast loads. In general, there was no difference in proteolytic activity of isolates from DM or control patients. Candida isolates from UK DM patients had significantly greater in vitro resistance to azole antifungal agents (miconazole p<0.0001 fluconazole p=0.02 ketoconazole p=0.01) than those from Italian DM patients. In addition, C. albicans isolates from all examined patients were more susceptible to fluconazole (p=0.0008) and miconazole (p=0.01) than non-C. albicans strains. PCR fingerprinting and subsequent phylogenetic analysis revealed that C. albicans isolates from UK DM patients were the most diverse (p<0.0001) in comparison to those from Italian DM patients or from healthy subjects. Finally, it was observed that the activity of a rat IgM monoclonal anti-idiotypic antibody (mAbKlO) and a synthetic decapeptide (KP) had a significant dose- dependant fungicidal activity upon a wide spectrum of C. albicans and non-C albicans isolates from patients with and without DM.
APA, Harvard, Vancouver, ISO, and other styles
8

Hanna, Natashi, and Salih Sonia Samir. "Övergången från pediatrisk vård till vuxenvård vid typ 1 diabetes : Patienternas upplevelser." Thesis, Ersta Sköndal högskola, Institutionen för vårdvetenskap, 2015. http://urn.kb.se/resolve?urn=urn:nbn:se:esh:diva-4999.

Full text
Abstract:
Bakgrund: Diabetes typ 1 är en sjukdom som medför stora förändringar i en persons liv. I denna förändring ingår flera övergångar, b.la. att övergå från frisk till sjuk men också övergå från pediatrisk vård till vuxenvård. Det är organisatoriska skillnader mellan den pediatriska vården och vuxenvården. Sjuksköterskan har olika roller i de två olika vårdformerna och på så sätt stöttas patienterna på olika sätt. Syfte: Syftet med denna studie var att beskriva patienternas upplevelser av övergång från pediatrisk vård till vuxenvård vid diabetes typ 1. Metod: Författarna har använt sig av en litteraturöversikt för att strukturera och skapa en överblick över det valda området och för att besvara syftet. Författarna har använt sig av tio vetenskapliga originalartiklar där de sammanställt ett resultat som svarar på denna litteraturöversikts Resultat: Resultatet visade att patienterna hade personliga åsikter kring utmaningarna under övergången. Patienterna hade olika inställningar inför övergången från pediatrisk vård till vuxenvård. Patienterna ansåg att förbättringar borde göras på organisationsnivå p.g.a. brist på struktur under övergången samt dålig kommunikation med patienterna. Diskussion: Sjuksköterskor är i behov av kunskap angående patienternas upplevelser av övergången för att kunna förbättra sin egen roll. När patienter övergår från pediatrisk vård till vuxenvård upplever de stress och påfrestningar på grund av sämre vägledning från den pediatriska vården. Både den pediatriska vården och vuxenvården är i behov av en praktisk struktur för övergången, detta för att dämpa känslor av oro som kan uppkomma hos patienterna.
Background: Diabetes type 1 is a disease that causes big changes in a person's life. The changes include various transitions, for an example transition from healthy to ill but also the transition from pediatric care to adult care. There are organizational differences between the pediatric care and adult care. Nurses have different roles in these two different treatment modalities that leads to the support being different too. Aim: The aim of this study was to describe patient’s experiences of transition from pediatric care to adult care of diabetes type 1. Method: A literature overview was used to structure and give the reader an overview of the selected area and to answer the purpose. Ten original scientific articles were used to compiled research that fulfill the purpose of this study Results: The result showed the patients personal views about the challenges during the transition. Patients had different feelings about the transition from pediatric care to adult care. The patients felt that improvements should be made in the organization level due to the bad structure during the transition. According to patients improvements should also be made with communication. Discussions: Nurses are in need of more knowledge about patients experiences of transition in order to improve their own role as a nurse. The patients feel stress and strain because of the transition from pediatric care to adult care. The patients felt stress also because there was no guidance from the health system under the transition period. The pediatric care and the adult care are in need of a structure to be able to decrease the unrest for patients.
APA, Harvard, Vancouver, ISO, and other styles
9

Pepe, Banza Kalenga. "The Profile of patients diagnosed with type 2 diabetes mellitus at Vanga Hospital, Dr Congo." Thesis, University of Limpopo (Medunsa Campus), 2010. http://hdl.handle.net/10386/780.

Full text
Abstract:
Thesis (Family Medicine)) -- University of Limpopo, 2010.
Background In the Vanga Health Zone, diabetic patients have idea that diabetes is due to witchcraft, which idea can interfere with the prevention and management of their disease. The purpose of this study was to determine the profile of patients diagnosed with type 2 diabetes mellitus at Vanga Hospital, Democratic Republic of Congo (DR Congo). Methods A cross-sectional study was designed with use of a questionnaire to a systematic sample of type 2 diabetic patients attending the diabetic clinic of Vanga hospital for at least six months and resident at Vanga health zone. Results Only 2.1 % of the participants believe in a scientific cause for diabetes; 53.5 % of them do not think that their disease is due to the fact that they crossed over a path where some ritual was performed and, 89.2 % of the participants believe that God deserted the person who suffered from diabetes and expect that prayer will rectify the disease. The majority of participants (65.6 %) had poor glycaemic control. Correlation analysis has shown that glycaemia level was not significantly associated with sociodemographic characteristics or health belief factors. Conclusion The majority of patients at the Vanga diabetic clinic have a greater need for management strategies to improve their glycaemic control. Keywords: type 2 diabetes mellitus, health beliefs, knowledge, sub-Saharan Africa, rural
APA, Harvard, Vancouver, ISO, and other styles
10

Walker, Kelly N. "Family functioning and diabetic ketoacidosis in pediatric patients with type i diabetes." [Gainesville, Fla.] : University of Florida, 2004. http://purl.fcla.edu/fcla/etd/UFE0004901.

Full text
Abstract:
Thesis (M.S.)--University of Florida, 2004.
Typescript. Title from title page of source document. Document formatted into pages; contains 42 pages. Includes Vita. Includes bibliographical references.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Diabetes mellitus Patients"

1

Langer, Anatoly. Silent myocardial ischemia in asymptomatic patients with diabetes mellitus. Ottawa: National Library of Canada, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Tattersall, Robert. Diabetes, a practical guide for patients on insulin. 2nd ed. Edinburgh: Churchill Livingstone, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Davis, Roger E. A. Studies on blood platelet subpopulations in relation to patients with diabetes mellitus. [s.l.]: typescript, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Kazantzaki, I. Anthropometric measurements in coronary heart disease patients with or without diabetes mellitus. London: University of Surrey Roehampton, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Diabetes in hospital: A practical approach for all healthcare professionals. Chichester, West Sussex, UK: J. Wiley & Sons, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Type 2 diabetes: Social and scientific origins, medical complications and implications for patients and others. Jefferson, N.C: McFarland & Co., 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Kagan, Andrew. Type 2 diabetes: Social and scientific origins, medical complications and implications for patients and others. Jefferson, N.C: McFarland & Co., 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Glycemic control in the hospitalized patient: A comprehensive clinical guide. New York: Springer, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

If your child has diabetes: An answer book for parents. New York, NY: Perigee Books, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

The ten keys to helping your child grow up with diabetes. Alexandria, Va: American Diabetes Assoc., 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Diabetes mellitus Patients"

1

Gorzelak-Pabiś, Paulina, and Marlena Broncel. "Diabetes Mellitus." In Hypotensive Syndromes in Geriatric Patients, 105–16. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-30332-7_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Krymskaya, Marina. "Resources for Patients with DiabetesResources for Patients with Diabetes." In Principles of Diabetes Mellitus, 1–8. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-20797-1_51-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Krymskaya, Marina. "Resources for Patients with Diabetes." In Principles of Diabetes Mellitus, 1047–54. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-18741-9_51.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Krymskaya, Marina. "Resources for Patients with Diabetes." In Principles of Diabetes Mellitus, 835–44. Boston, MA: Springer US, 2009. http://dx.doi.org/10.1007/978-0-387-09841-8_51.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Reilly, Eileen, Laura Ronen, and Mary Beyreuther. "Resources for Patients with Diabetes." In Principles of Diabetes Mellitus, 759–70. Boston, MA: Springer US, 2004. http://dx.doi.org/10.1007/978-1-4757-6260-0_41.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Squires, Ray W., and Kerry J. Stewart. "Cardiac Rehabilitation for Patients with Diabetes Mellitus." In Contemporary Diabetes, 319–27. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-61013-9_21.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Mendoza, Maria A. "Teaching and Motivating Patients to Achieve Treatment Goals." In Principles of Diabetes Mellitus, 823–42. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-18741-9_40.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Mendoza, Maria A. "Teaching and Motivating Patients to Achieve Treatment Goals." In Principles of Diabetes Mellitus, 1–20. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-20797-1_40-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Karagiorga-Lagana, M., A. Chatziliami, A. Katsantoni, F. Karabatsos, C. Fragodimitri, G. Tapaki, J. Jousef, M. Giannaki, and A. Al-Qadreh. "Secondary Diabetes mellitus in Thalassemic Patients." In Endocrine Disorders in Thalassemia, 161–65. Milano: Springer Milan, 1995. http://dx.doi.org/10.1007/978-88-470-2183-9_30.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Miles, Anne Marie. "Hemodialysis in patients with diabetes mellitus." In Diabetic Renal-Retinal Syndrome, 79–87. Dordrecht: Springer Netherlands, 1998. http://dx.doi.org/10.1007/978-94-011-4962-4_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Diabetes mellitus Patients"

1

Elcin, Huseyn. "EARLY IDENTIFICATION OF THE NEUROLOGICAL COMPLICATIONS OF DIABETES MELLITUS." In International Trends in Science and Technology. RS Global Sp. z O.O., 2021. http://dx.doi.org/10.31435/rsglobal_conf/30032021/7474.

Full text
Abstract:
Diabetes mellitus is still a very common disease in the world and affects the daily lives of patients negatively. Diabetes is also known to be associated with neurological diseases such as peripheral nerve diseases, stroke and dementia. Among these, the most common disease is a peripheral nerve disease, and it has been reported that poor diabetic control increases the risk of development and can be prevented by education of the patients. Vascular dementia is more common in patients with diabetes than Alzheimer's disease, and it is thought that cerebrovascular diseases may berelated to cognitive impairment in diabetes. Although the mechanisms by which diabetes affects the brain are not clearly revealed, it is thought that changes in vascular structure, insulin resistance, glucose toxicity, oxidative stress, accumulation of glycation end products, hypoglycemic episodes and amyloid metabolism are effective.The aim of this article is to describe the neurological complications of diabetes and to emphasize the importance of patient education, good diabetes control and early diagnosis in preventing these complications.
APA, Harvard, Vancouver, ISO, and other styles
2

Sandbjerg Hansen, M., and B. Milner Jørgensen. "FUNCTIONAL CHANGES IN ANTITHROMBIN III IN INSULIN-DEPENDENT DIABETES MELLITUS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643104.

Full text
Abstract:
The thrombin neutralizing activity of Antithrombin III (AT) was measured in a group of patients with insulin-dependent diabetes mellitus. All patients evaluated had diabetes of several years duration. Their blood glucose control was unsatisfactory as evidenced by relative concentrations of glycated hemoglobin (HbA1c) of 9.6-14.0% determined by polyacrylamide gel electrophoresis. The plasma AT-activity was estimated as thrombin neutralizing activity using the chromogenic substrate Th-1.The group of diabetic patients had a higher AT-activity than a reference group, but normal AT-concentrations by electro-immunoassay. The treatment of the patient samples with neuraminidase caused a greater fall in the AT-activity than did the treatment of normal samples. The patient samples had a slower mobility in crossed affino-immunoelectrophoresis using immobilized helix pomatia lectin in the first dimension and specific antibodies against AT in the second dimension. The mobility of patient AT, also in complex with thrombin, was indistinguishable from normal AT in crossed immunoelectrophoresis in the presence or absence of heparin.It is concluded that long-term dysregulation of diabetes mellitus may induce functional changes in the plasma antithrombin activity.
APA, Harvard, Vancouver, ISO, and other styles
3

Alava, I., L. J. Garcia Frade, H. de la Calle, J. L. Havarro, L. J. Creighton, and P. J. Gaffney. "DIABETES MELLITUS: HYPERCOAGULABILITY AID HYPOFIBRIHOLYSIS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643108.

Full text
Abstract:
A hypercoagulable state has been related to the presence of microvascular and macrovascular disease in Diabetes Mellitus. The aim of this study was to establish when this hypercoagulable state appears and the response of the fibrinolytic system.43 patients (29 males, 14 females, aged 19-73), 28 insulin-dependent (10 of them with micro and/or macrovascular disease), 15 non insulin- dependent (all of them with vascular disease) were studied.Platelet aggregation and adenine nucleotides, plasma and serum thromboxane B2 (TxB2), Factor VIII Coagulant (VIII-C), Factor VIII Related antigen (VIII-RAg), Factor VIII Ristocetin Cofactor (VIII-RCoF), Fibronectin, Tissue Plasminogen Activator (t-PA) and X-Oligomers fibrin fragments were measured.In the diabetic patients maximal aggregation was induced by a threshold concentration of adenosin diphosphate and arachidonic acid lower than in controls (p<0.01 and p<0.05). Diabetic patients also presented elevated platelet ADP and decreased platelet c-AMP. They had higher plasma TxB* levels than the control group.FVIII-C, FVIII-RAg and Fibronectin were increased (p<0.001) both in patients type I and II, with and without vasculopathy. FVIII-RCoF was highly increased in vasculopathy (p<0.001) while was non significant without it.The patients with vasculopathy presented decreased t-PA plasma levels (p<0.05). lo difference in X-Oligomers was found related to controls.These findings suggest: 1) A hypercoagulable state previously to the development of clinical vasculopathy. 2) A decreased fibrinolytic response associated to vasculopathy.
APA, Harvard, Vancouver, ISO, and other styles
4

Treterova, Silvie. "PROPHYLACTIC FOOTWEAR IN ELDERLY PATIENTS WITH DIABETES MELLITUS." In 6th SWS International Scientific Conference on Social Sciences ISCSS 2019. STEF92 Technology, 2019. http://dx.doi.org/10.5593/sws.iscss.2019.3/s12.082.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Aliev, M. M. ogly, and E. A. ogly Museibov. "Treatment of urolithiasis in patients with diabetes mellitus." In Scientific dialogue: Medical issues. ЦНК МОАН, 2019. http://dx.doi.org/10.18411/spc-15-05-2019-02.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Korkontzelou, Aliki, Stamatina Driva, Sotiria Schoretsaniti, Sotiris Gyftopoulos, Vasiliki Vasileiou, Zafeiria Barbaressou, Alexander Osarogue, et al. "Smoking cessation in patients with Diabetes Mellitus (DM)." In ERS International Congress 2020 abstracts. European Respiratory Society, 2020. http://dx.doi.org/10.1183/13993003.congress-2020.3065.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bayareh, R., H. Maldonado, I. A. Torres, A. Vera, and L. Leija. "Thermographic study of the diabetic foot of patients with diabetes mellitus and healthy patients." In 2018 Global Medical Engineering Physics Exchanges/Pan American Health Care Exchanges (GMEPE/PAHCE). IEEE, 2018. http://dx.doi.org/10.1109/gmepe-pahce.2018.8400742.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Kun’ain, Utin Ilma Agni, Setyo Sri Rahardjo, and Didik Gunawan Tamtomo. "Meta-Analysis: The Effect of Diabetes Mellitus Comorbidity on the Severity in Patients with Covid-19 Infection." In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.05.57.

Full text
Abstract:
Background: Previous studies reported that adults with certain comorbid conditions are at increased risk for severe illness of Covid-19. The purpose of this meta-analysis study was to assess the effect of diabetes mellitus comorbidity on the severity in patients with Covid-19 infection. Subjects and Method: Meta-analysis and systematic review was conducted by collecting articles from Pubmed, Google Scholar, and Springer Link online databases, from 2019 to 2020. Keywords used “COVID-19 and comorbidity”, “COVID-19 and severity and diabetes”, “comorbidity or severity or diabetes or adjusted odd ratio”. The inclusion criteria were full text, using English and Indonesian language, using observational study, primary study in hospital. The study population (P) was COVID-19 patients. Intervention (I) was diabetes mellitus with comparison (C) without diabetes mellitus. The study outcome (O) was risk of severity. The data were analyzed using random effect model in Revman 5.3. Results: There were 6 studies from South Korea, United States, and China. This study had high heterogeneity (I2= 65%, p= 0.01). DM comorbidity increased the risk of severity 2.74 times in patients with comorbidity than those without DM comorbidity (aOR=2.74; 95% CI= 1.37 to 5.48; p=0.004). Conclusion: Diabetes mellitus comorbidity increases the risk of severity in patients with COVID-19. Keywords: COVID-19, severity, diabetes mellitus, comorbidity Correspondence: Utin Ilma Agni Kun’ain. Masters Program in Public Health, Universitas Sebelas Maret. Jl. Ir. Sutami 36A, Surakarta 57126, Central Java. Email: utinilmaagni8p@gmail.com Mobile: +628111044542. DOI: https://doi.org/10.26911/the7thicph.05.57
APA, Harvard, Vancouver, ISO, and other styles
9

Septiani, Anissa Eka, Bhisma Murti, Setyo Sri Rahardjo, and Hanung Prasetya. "Meta-Anaylsis: Gender and the Risk of Lower Extremity Amputation in Patients with Type 2 Diabetes Mellitus and Foot Ulcer." In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.01.37.

Full text
Abstract:
ABSTRACT Background: Diabetes is an independent predictor of limb amputation (versus revascularization) for the treatment of critical limb ischemia. Much of the cost related to diabetes results from macrovascular and microvascular complications, such as myocardial infarctions, end-stage renal disease, and lower extremity amputations (LEAs). This study aimed to examine the associations between gender and the risk of lower extremity amputation in patients with type 2 diabetes mellitus and foot ulcer. Subjects and Method: A meta-analysis and systematic review was conducted by collected published articles from Pubmed, Scopus, Google Scholar, and Springer Link databases. Lower limb amputation, lower extremity amputation, diabetic foot, and diabetic ulcer keywords were used to collect the articles. The inclusion criteria were full text, cohort study, and reporting adjusted odds ratio. The selected articles were analyzed by PRISMA flow chart and revman 5.3. Results: 9 articles were reported that male increased the risk of lower extremity amputation in type 2 DM patients (aOR= 1.60; 95% CI= 1.32 to 1.94; p<0.001). Conclusion: Male increases the risk of lower extremity amputation in type 2 DM patients. Keywords: lower extremity amputation, type 2 diabetes mellitus, foot ulcer Correspondence: Anissa Eka Septiani. Masters Program in Public Heath, Universitas Sebelas Maret. Jl. Ir. Sutami 36A, Surakarta 57126, Central Java, Indonesia. Email: sanissaeka@gmail.com. Mobile: 089514646458. DOI: https://doi.org/10.26911/the7thicph.01.37
APA, Harvard, Vancouver, ISO, and other styles
10

Montani, N., S. B. Solerte, G. Gamba, M. Fioravanti, and E. Ferrari. "RELATIONSHIPS BETWEEN HAEMOSTATIC ENDOTHELIAL FUNCTIONS AND GLOMERULAR FILTRATION RATE IN SHORT-TERM TYPE I DIABETES MELLITUS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643101.

Full text
Abstract:
It is known that the increase of glomerular filtration rate (GFR) represents an early sign of diabetic nephropathy. The changes of endothelial functions observed in diabetes might play a role in this respect. As F VIII vWF and fibronectin are synthetized by endothelial cells, we evaluated these components in 33 diabetic patients with short-term Type I (insulin dependent) diabetes mellitus, without retinopathy and macro-vascular complications. 15 pts. (mean age 29 ± 7 yrs; mean diabetes duration 2.9 ± 0.9 yrs) presented high GFR (154 ± 19 ml/min per 1.73 m2 ; albuminuria 7.2 ± 3.2 μg/min) and 18 pts. (mean age 30 ± 6 yrs; mean diabetes duration 3.0 ± 1 yrs) normal GFR (105 ± 11 ml/min per 1.73 m2 ; albuminuria 5 ± 2.8 μg/min).The following results were obtained:In conclusion the significant increase of FVIIIR:Ag and fibronectin levels in short-time type I diabetic patients with high GFR suggests an early endothelial cell function damage also related to the Door metabolic control.
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Diabetes mellitus Patients"

1

Cui, Sufen. Acupuncture for chronic constipation in patients with diabetes mellitus: a systematic review protocol. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, January 2021. http://dx.doi.org/10.37766/inplasy2021.1.0079.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Mermeklieva, Elena. Comparative Analysis of Pattern Electroretinography Values According to the Type of Diabetes Mellitus in Patients in Different Diabetic Retinopathy Stages. "Prof. Marin Drinov" Publishing House of Bulgarian Academy of Sciences, May 2021. http://dx.doi.org/10.7546/crabs.2021.05.18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Colonetti, Tamy, Micheli Mariot, Laura Colonetti, and Marina Costa. Effects of gluten free diet in patients with diabetes mellitus type1: systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, June 2020. http://dx.doi.org/10.37766/inplasy2020.6.0010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Deo, Salil, David McAllister, Naveed Sattar, and Jill Pell. The time-varying cardiovascular benefits of glucagon like peptide-1 agonist (GLP-RA)therapy in patients with type 2 diabetes mellitus: A meta-analysis of multinational randomized trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, July 2021. http://dx.doi.org/10.37766/inplasy2021.7.0097.

Full text
Abstract:
Review question / Objective: P - patients with type 2 diabetes melllitus already receiving routine medical therapy; I - patients receiving glucagon like peptide 1 receptor agonist (GLP1 receptor agonist) therapy (semaglutide, dulaglutide, liraglutide, exenatide, lixisenatide, efpeglenatide, abiglutide); C - patients receiving standard therapy for diabetes mellitus but not receiving GLP1 agonist therapy; O - composite end point as per invididual trial, cardiovascular mortality, all-cause mortality, myocardial infarction, stoke. Condition being studied: Type 2 diabetes mellitus. Study designs to be included: Randomised controlled trials which enroll a large number of patients (defined as > 500) and are multinational in origin. Studies included will need to have published Kaplan and Meier curves for the end-points presented in the manuscript.
APA, Harvard, Vancouver, ISO, and other styles
5

Mermeklieva, Elena, Silvia Cherninkova, Violeta Chernodrinska, Dimitar Solakov, Greta Grozeva, Maria Tomova, and Ljudmila Todorova. Combined Electrophysiological Method for Early Diagnostics of Functional Changes in the Visual Analyzer in Patients with Diabetes Mellitus withоut Diabetic Retinopathy. "Prof. Marin Drinov" Publishing House of Bulgarian Academy of Sciences, May 2019. http://dx.doi.org/10.7546/crabs.2019.05.16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Htet, Norah Htet, Cho Naing, Wong Siew Tung, and Joon Wah Mak. The effect of metformin on gastric cancer in patients with type 2 diabetes mellitus: an umbrella review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, March 2021. http://dx.doi.org/10.37766/inplasy2021.3.0110.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Cui, Haiying, Yao Wang, Shuo Yang, Guangyu He, Zongmiao Jiang, Xiaokun Gang, and Guixia Wang. Antidiabetic Medications and the Risk of Prostate Cancer in Patients with Diabetes Mellitus: A Systematic Review and Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, June 2020. http://dx.doi.org/10.37766/inplasy2020.6.0113.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Tian, Hao. Efficacy of laparoscopic sleeve gastrectomy in obese patients with type 2 diabetes mellitus: a protocol of systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review Protocols, April 2020. http://dx.doi.org/10.37766/inplasy2020.4.0128.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Tian, Hao. Effect of roux-en Y gastric bypass surgery on patients with type 2 diabetes mellitus: a protocol of systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review Protocols, April 2020. http://dx.doi.org/10.37766/inplasy2020.4.0127.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Jiawei, Cai, Chen Junmin, Zeng Qianqian, Liu Jie, Zhang Yanli, and Chen Qiu. Assessment of the efficacy of α-lipoic acid in treatment of diabetes mellitus patients with erectile dysfunction: a protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, July 2020. http://dx.doi.org/10.37766/inplasy2020.7.0130.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Diabetes mellitus Patients' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography